Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective lowered by Canaccord Genuity Group from $57.00 to ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Tandem Diabetes Care, Inc. TNDM posted a third-quarter 2024 loss of 36 cents per share compared with the year-ago quarter’s ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Bernstein has recently initiated Tandem Diabetes Care Inc (TNDM) stock to Outperform rating, as announced on Today, according to Finviz. Earlier, on October 4, 2024, Goldman had initiated the stock to ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

SAN DIEGO, October 30, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and ...

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...

Susan Morrison; Executive Vice President, Chief Administrative Officer; Tandem Diabetes Care Inc John Sheridan; President, Chief Executive Officer, Director; Tandem Diabetes Care Inc Leigh Vosseller; ...